PRAGUE.BIO HAS EXPANDED ITS RANKS WITH A SIGNIFICANT INDUSTRY REPRESENTATIVE - ZENTIVA JOINS THE ASSOCIATION

Prague, May 13, 2024 - Prague.bio is a professional association aimed at developing the biotechnology sector in the Czech Republic and assisting in its visibility on the international stage. So far, it has brought together institutions representing highly professional research centers with a strong influence on the development of new drugs, diagnostic methods, and other medical technologies. Now, the first industry representative, Zentiva, has joined the Prague.bio biotechnology cluster.

 

Prague.bio Biotechnology Cluster was established last autumn and so far has consisted of six institutions from the academic environment: the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, the biotechnology incubator i&i Prague, the Biotechnology Institute of the Czech Academy of Sciences, the Institute of Microbiology of the Czech Academy of Sciences, the Institute of Molecular Genetics of the Czech Academy of Sciences, and the University of Chemistry and Technology in Prague. Now, the first industry representative is joining them.

 

"Zentiva's accession is a breakthrough moment for Prague.bio, as it represents an important step towards fulfilling the association's basic mission, which is to connect science, industry, and business. At the same time, we are very pleased that the first non-academic representative in our association is Zentiva, a successful international company based in the Czech Republic, which, in addition to manufacturing, also has a global research and development center and ranks among the top 10 investors in research and development in the Czech Republic," says Petra Kinzlová, CEO of Prague.bio.

 

Sharing and cooperation for the development of innovative potential

 

Zentiva's accession to the association builds on mutual cooperation during the first year of the Prague.bio conference, which Zentiva representatives actively participated in last year. "The pharmaceutical industry has a long tradition in the Czech Republic. At Zentiva, we care about its maintenance, growth, and bringing innovation and accessible treatment to those who need it. We have long been involved in the development of Czech pharmaceutical science through the education of industry professionals and close cooperation with universities, for example, within the Applied Research Center The PARC. Joining Prague.bio is another logical step for us in building domestic pharmaceutical potential, and we are pleased to have found another partner who shares our vision," says Martin Albert, Chief Scientific Officer at Zentiva.